Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
OLMA
OLMA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
OLMA News
Olema Pharmaceuticals to Participate in Upcoming Investor Conferences
Feb 04 2026
Newsfilter
Olema Pharmaceuticals Grants Stock Options to New Employees
Feb 03 2026
Newsfilter
Olema Pharmaceuticals CFO Departure and Succession Plan
Jan 30 2026
seekingalpha
Analysis of OLMA Options Contracts and Investment Opportunities
Jan 30 2026
NASDAQ.COM
Glaukos Corp (GKOS) Projects FY25 Sales of $507 Million, Shares Drop 12.1%
Jan 14 2026
Benzinga
Olema Pharmaceuticals Board Member Sells 264,800 Shares for $7.9 Million
Jan 09 2026
Fool
Olema Oncology Board Member Sells $7.87 Million in Stock
Jan 09 2026
NASDAQ.COM
Olema Pharmaceuticals (OLMA) Receives Buy Rating with $45 Price Target
Jan 07 2026
Yahoo Finance
Olema Pharmaceuticals to Present at 44th J.P. Morgan Healthcare Conference on January 13, 2025
Jan 05 2026
Globenewswire
Kyverna Therapeutics, Immunome, Almonty Industries, and Other Major Stocks Rise on Monday
Dec 15 2025
Benzinga
Roku Set for Over 28% Surge? Check Out 10 Leading Analyst Predictions for Thursday
Dec 11 2025
Benzinga
Olema Grants 65,000 Stock Options to New Employees to Enhance Talent Acquisition
Dec 02 2025
Globenewswire
Olema Pharmaceuticals Grants 65,000 Stock Options to New Employees
Dec 02 2025
Newsfilter
Goldman Sachs Reaffirms Buy Rating on Olema Pharmaceuticals, Increases Price Target to $26
Nov 21 2025
Benzinga
"Invest in Olema Pharmaceuticals at $16 and Achieve 40.4% Annualized Returns with Options"
Nov 21 2025
NASDAQ.COM
Nutex Health Reports Impressive Q3 Performance, Partners with PACS Group, While Walmart, Cerence, and Other Major Stocks Rise on Thursday
Nov 20 2025
Benzinga
Show More News
